Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Gastrointestinal Infections specialty page provides gastrointestinal infection-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

GASTROINTESTINAL INFECTIONS NEWS - Page 1

Bimodal Release Oral Ondansetron Shows Promise in Phase 3 Study
Intravenous treatment of acute gastroenteritis can be costly and uncomfortable. A phase 3 clinical trial showed positive results for a bimodal release oral ondansetron tablet, finding the drug effective in treating nausea and vomiting.  
 
FDA Approves RHB-105 to Treat <i>H Pylori</i>
RHB-105 (Talicia) is the only rifabutin-based therapy approved for the treatment of H pylori infection and is designed to address the high resistance of H pylori bacteria to current clarithromycin-based standard-of-care therapies. 
ERADICATE Hp2: RHB-105 Could Fill Treatment Gap for <i>H Pylori</i>
RHB-105 is an “all-in-one” fixed-dose oral capsule comprising rifabutin 50 mg, amoxicillin 1000 mg, and omeprazole 40 mg.
Antibiotic-Resistant <i>H Pylori</i> is on the Rise in Europe
Helicobacter pylori resistance to clarithromycin more than doubled during the past 20 years, according to new research presented at UEG Week Barcelona 2019.
As Hurricane Season Begins, Officials Prepare for Potential Outbreaks
Natural disasters like hurricanes can have implications for public health, including a heightened risk of infectious diseases.
Essential Vaccines by Age Group
As outbreaks of vaccine-preventable diseases grow, it is important to review vaccination recommendations by age group.
Rate of Cryptosporidiosis Outbreaks Linked to Pools and Water Parks Growing
Outbreaks of the water-borne pathogen increased an average of 13% each year between 2009 and 2017.
Alison Lew, PharmD: Vancomycin Prophylaxis for CDI Recurrence
At MAD-ID 2019, Alison Lew, PharmD, spoke about her research on oral vancomycin prophylaxis to reduce CDI recurrence. 
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?